vs
Side-by-side financial comparison of Gossamer Bio, Inc. (GOSS) and INTERGROUP CORP (INTG). Click either name above to swap in a different company.
INTERGROUP CORP is the larger business by last-quarter revenue ($17.3M vs $13.8M, roughly 1.3× Gossamer Bio, Inc.). INTERGROUP CORP runs the higher net margin — 8.8% vs -342.3%, a 351.1% gap on every dollar of revenue. On growth, Gossamer Bio, Inc. posted the faster year-over-year revenue change (47.1% vs 19.8%).
Gossamer Bio, Inc. is a clinical-stage biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics for patients with serious immunology, inflammation and oncology conditions. It advances a pipeline of proprietary product candidates across multiple clinical phases, primarily serving healthcare markets in North America and other global regions.
Intergroup Corp is a diversified holding firm operating two core segments: real estate and hotel operations. It owns, manages and leases commercial and residential properties across the U.S., and runs limited-service hotels for leisure and business travelers.
GOSS vs INTG — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $13.8M | $17.3M |
| Net Profit | $-47.2M | $1.5M |
| Gross Margin | — | — |
| Operating Margin | -333.6% | 11.6% |
| Net Margin | -342.3% | 8.8% |
| Revenue YoY | 47.1% | 19.8% |
| Net Profit YoY | -43.0% | 155.6% |
| EPS (diluted) | $-0.21 | $0.71 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $13.8M | $17.3M | ||
| Q3 25 | $13.3M | $17.9M | ||
| Q2 25 | — | $16.2M | ||
| Q1 25 | — | $16.8M | ||
| Q4 24 | — | $14.4M | ||
| Q3 24 | — | $16.9M | ||
| Q2 24 | $95.8M | $13.4M | ||
| Q1 24 | $0 | $14.9M |
| Q4 25 | $-47.2M | $1.5M | ||
| Q3 25 | $-48.2M | $-535.0K | ||
| Q2 25 | — | $-2.2M | ||
| Q1 25 | — | $-578.0K | ||
| Q4 24 | — | $-2.7M | ||
| Q3 24 | — | $-398.0K | ||
| Q2 24 | $49.2M | $-4.9M | ||
| Q1 24 | $-41.9M | $-3.2M |
| Q4 25 | -333.6% | 11.6% | ||
| Q3 25 | -369.4% | 15.3% | ||
| Q2 25 | — | 8.1% | ||
| Q1 25 | — | 14.0% | ||
| Q4 24 | — | 5.9% | ||
| Q3 24 | — | 18.5% | ||
| Q2 24 | 54.3% | 3.7% | ||
| Q1 24 | — | 4.8% |
| Q4 25 | -342.3% | 8.8% | ||
| Q3 25 | -362.7% | -3.0% | ||
| Q2 25 | — | -13.9% | ||
| Q1 25 | — | -3.4% | ||
| Q4 24 | — | -18.9% | ||
| Q3 24 | — | -2.4% | ||
| Q2 24 | 51.4% | -36.7% | ||
| Q1 24 | — | -21.3% |
| Q4 25 | $-0.21 | $0.71 | ||
| Q3 25 | $-0.21 | $-0.25 | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $-0.27 | ||
| Q4 24 | — | $-1.26 | ||
| Q3 24 | — | $-0.18 | ||
| Q2 24 | $0.22 | — | ||
| Q1 24 | $-0.19 | $-1.44 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $136.9M | $7.5M |
| Total DebtLower is stronger | — | $233.2M |
| Stockholders' EquityBook value | $-122.8M | $-85.2M |
| Total Assets | $172.2M | $101.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $136.9M | $7.5M | ||
| Q3 25 | $180.2M | $6.0M | ||
| Q2 25 | — | $6.1M | ||
| Q1 25 | — | $4.8M | ||
| Q4 24 | — | $15.4M | ||
| Q3 24 | — | $12.2M | ||
| Q2 24 | $354.5M | $11.6M | ||
| Q1 24 | $244.4M | $19.5M |
| Q4 25 | — | $233.2M | ||
| Q3 25 | — | $237.8M | ||
| Q2 25 | — | $240.5M | ||
| Q1 25 | — | $241.5M | ||
| Q4 24 | — | $227.2M | ||
| Q3 24 | — | $218.1M | ||
| Q2 24 | — | $225.7M | ||
| Q1 24 | — | $225.0M |
| Q4 25 | $-122.8M | $-85.2M | ||
| Q3 25 | $-82.3M | $-86.7M | ||
| Q2 25 | — | $-86.1M | ||
| Q1 25 | — | $-84.5M | ||
| Q4 24 | — | $-83.9M | ||
| Q3 24 | — | $-80.9M | ||
| Q2 24 | $81.5M | $-80.3M | ||
| Q1 24 | $26.7M | $-76.4M |
| Q4 25 | $172.2M | $101.1M | ||
| Q3 25 | $208.8M | $102.5M | ||
| Q2 25 | — | $104.1M | ||
| Q1 25 | — | $103.2M | ||
| Q4 24 | — | $110.6M | ||
| Q3 24 | — | $109.3M | ||
| Q2 24 | $373.4M | $107.8M | ||
| Q1 24 | $259.4M | $119.0M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-48.3M | $-23.0K |
| Free Cash FlowOCF − Capex | — | $-481.0K |
| FCF MarginFCF / Revenue | — | -2.8% |
| Capex IntensityCapex / Revenue | 0.0% | 2.6% |
| Cash ConversionOCF / Net Profit | — | -0.02× |
| TTM Free Cash FlowTrailing 4 quarters | — | $739.0K |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-48.3M | $-23.0K | ||
| Q3 25 | $-36.2M | $-296.0K | ||
| Q2 25 | — | $5.9M | ||
| Q1 25 | — | $-854.0K | ||
| Q4 24 | — | $-781.0K | ||
| Q3 24 | — | $3.4M | ||
| Q2 24 | $116.3M | $6.8M | ||
| Q1 24 | $-52.3M | $1.9M |
| Q4 25 | — | $-481.0K | ||
| Q3 25 | — | $-1.3M | ||
| Q2 25 | — | $3.6M | ||
| Q1 25 | — | $-1.2M | ||
| Q4 24 | — | $-1.1M | ||
| Q3 24 | — | $3.1M | ||
| Q2 24 | — | $2.7M | ||
| Q1 24 | — | $1.1M |
| Q4 25 | — | -2.8% | ||
| Q3 25 | — | -7.1% | ||
| Q2 25 | — | 22.5% | ||
| Q1 25 | — | -6.8% | ||
| Q4 24 | — | -7.8% | ||
| Q3 24 | — | 18.3% | ||
| Q2 24 | — | 20.4% | ||
| Q1 24 | — | 7.6% |
| Q4 25 | 0.0% | 2.6% | ||
| Q3 25 | 0.0% | 5.4% | ||
| Q2 25 | — | 13.9% | ||
| Q1 25 | — | 1.8% | ||
| Q4 24 | — | 2.4% | ||
| Q3 24 | — | 1.6% | ||
| Q2 24 | 0.0% | 30.4% | ||
| Q1 24 | — | 4.9% |
| Q4 25 | — | -0.02× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 2.36× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GOSS
Segment breakdown not available.
INTG
| Hotel Operations | $12.7M | 73% |
| Real Estate Operation | $4.6M | 27% |
